Risk factors for developing ILD in SSc include anti-SCL-70 and speckled antinuclear antibodies positivity, anti-TRIM21 positivity, male gender, African American race, diffuse disease form, recent disease onset (within the first 5–7 years), and elevated acute phase reactants [28]. The gene discussed is TRIM21; the disease is systemic sclerosis.